{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:34:19Z","timestamp":1794375259444,"version":"4.9.0"},"reference-count":105,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Evidence-based guidelines for the management of patients with histoplasmosis were prepared by an Expert Panel of the Infectious Diseases Society of America. These updated guidelines replace the previous treatment guidelines published in 2000 (Clin Infect Dis 2000; 30:688\u201395). The guidelines are intended for use by health care providers who care for patients who either have these infections or may be at risk for them. Since 2000, several new antifungal agents have become available, and clinical trials and case series have increased our understanding of the management of histoplasmosis. Advances in immunosuppressive treatment for inflammatory disorders have created new questions about the approach to prevention and treatment of histoplasmosis. New information, based on publications from the period 1999\u20132006, are incorporated into this guideline document. In addition, the panel added recommendations for management of histoplasmosis in children for those aspects that differ from aspects in adults.<\/jats:p>","DOI":"10.1086\/521259","type":"journal-article","created":{"date-parts":[[2007,9,4]],"date-time":"2007-09-04T13:27:17Z","timestamp":1188912437000},"page":"807-825","source":"Crossref","is-referenced-by-count":1196,"title":["Clinical Practice Guidelines for the Management of Patients with Histoplasmosis: 2007 Update by the Infectious Diseases Society of America"],"prefix":"10.1093","volume":"45","author":[{"given":"L. Joseph","family":"Wheat","sequence":"first","affiliation":[{"name":"\u00a0MiraVista Diagnostics\/MiraBella Technologies, Indianapolis, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison G.","family":"Freifeld","sequence":"additional","affiliation":[{"name":"\u00a0University of Nebraska Medical Center, Omaha"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"Kleiman","sequence":"additional","affiliation":[{"name":"\u00a0Indiana University School of Medicine, Indianapolis, Indiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W.","family":"Baddley","sequence":"additional","affiliation":[{"name":"\u00a0University of Alabama, Birmingham"},{"name":"\u00a0Birmingham Veterans Affairs Medical Center, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"McKinsey","sequence":"additional","affiliation":[{"name":"\u00a0ID Associates of Kansas City, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Loyd","sequence":"additional","affiliation":[{"name":"\u00a0Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Kauffman","sequence":"additional","affiliation":[{"name":"\u00a0Veterans Affairs Medical Center, University of Michigan Medical School, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2007,10,1]]},"reference":[{"key":"2020110410311771800_ref1","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1086\/313752","article-title":"Practice guidelines for the management of patients with histoplasmosis. Infectious Diseases Society of America","volume":"30","author":"Wheat","year":"2000","journal-title":"Clin Infect Dis"},{"key":"2020110410311771800_ref2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.17226\/1626","article-title":"Institute of Medicine Committee to Advise the Public Health Service on Clinical Practice Guidelines","volume-title":"Clinical practice guidelines: directions for a new program","author":"Field","year":"1990"},{"key":"2020110410311771800_ref3","first-page":"1193","article-title":"The periodic health examination","volume":"121","author":"Canadian Task Force on the Periodic Health Examination","year":"1979","journal-title":"CMAJ"},{"key":"2020110410311771800_ref4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1055\/s-2004-824898","article-title":"Pulmonary histoplasmosis syndromes: recognition, diagnosis, and management","volume":"25","author":"Wheat","year":"2004","journal-title":"Semin Respir Crit Care Med"},{"key":"2020110410311771800_ref5","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/01.icu.0000161228.21797.d9","article-title":"New and classic insights into presumed ocular histoplasmosis syndrome and its treatment","volume":"16","author":"Oliver","year":"2005","journal-title":"Curr Opin Ophthalmol"},{"key":"2020110410311771800_ref6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0002-9394(68)91797-2","article-title":"Amphotericin B therapy in the treatment of presumed histoplasma chorioretinitis: a further appraisal","volume":"66","author":"Giles","year":"1968","journal-title":"Am J Ophthalmol"},{"key":"2020110410311771800_ref7","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7326\/0003-4819-75-4-511","article-title":"Disseminated histoplasmosis: results of long-term follow-up: a Center for Disease Control cooperative mycoses study","volume":"75","author":"Sarosi","year":"1971","journal-title":"Ann Intern Med"},{"key":"2020110410311771800_ref8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/0003-4819-137-2-200207160-00008","article-title":"Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS","volume":"137","author":"Johnson","year":"2002","journal-title":"Ann Intern Med"},{"issue":"Suppl 6","key":"2020110410311771800_ref9","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/429331","article-title":"Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex","volume":"40","author":"Perfect","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2020110410311771800_ref10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0002-9343(92)90575-V","article-title":"Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group","volume":"93","author":"Dismukes","year":"1992","journal-title":"Am J Med"},{"key":"2020110410311771800_ref11","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0002-9343(99)80311-8","article-title":"Itraconazole treatment of disseminated histoplasmosis in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trial Group","volume":"98","author":"Wheat","year":"1995","journal-title":"Am J Med"},{"key":"2020110410311771800_ref12","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1128\/AAC.44.7.1850-1854.2000","article-title":"Comparison of the echinocandin caspofungin with amphotericin B for treatment of histoplasmosis following pulmonary challenge in a murine model","volume":"44","author":"Kohler","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2020110410311771800_ref13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1128\/AAC.42.1.151","article-title":"Treatment of histoplasmosis with MK-991 (L-743,872)","volume":"42","author":"Graybill","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"2020110410311771800_ref14","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1128\/JCM.36.10.2950-2956.1998","article-title":"Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts","volume":"36","author":"Espinel-Ingroff","year":"1998","journal-title":"J Clin Microbiol"},{"key":"2020110410311771800_ref15","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/clinids\/23.5.996","article-title":"Fluconazole therapy for histoplasmosis. The National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"23","author":"McKinsey","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2020110410311771800_ref16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0002-9343(97)00151-4","article-title":"Treatment of histoplasmosis with fluconazole in patients with acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Acquired Immunodeficiency Syndrome Clinical Trials Group and Mycoses Study Group","volume":"103","author":"Wheat","year":"1997","journal-title":"Am J Med"},{"key":"2020110410311771800_ref17","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1086\/323781","article-title":"Emergence of resistance to fluconazole as a cause of failure during treatment of histoplasmosis in patients with acquired immunodeficiency disease syndrome","volume":"33","author":"Wheat","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2020110410311771800_ref18","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/jac\/dkl133","article-title":"Activity of newer triazoles against Histoplasma capsulatum from patients with AIDS who failed fluconazole","volume":"57","author":"Wheat","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"2020110410311771800_ref19","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1128\/AAC.44.10.2604-2608.2000","article-title":"Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice","volume":"44","author":"Connolly","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2020110410311771800_ref20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5858\/2006-130-120-AYWWAI","article-title":"A 43-year-old woman with acquired immunodeficiency syndrome and fever of undetermined origin: disseminated histoplasmosis","volume":"130","author":"Al-Agha","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"2020110410311771800_ref21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00024720-200304000-00016","article-title":"Intramedullary histoplasmosis spinal cord abscess in a nonendemic region: case report and review of the literature","volume":"16","author":"Hott","year":"2003","journal-title":"J Spinal Disord Tech"},{"key":"2020110410311771800_ref22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1467-8365.2005.00105.x","article-title":"Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center","volume":"7","author":"Freifeld","year":"2005","journal-title":"Transpl Infect Dis"},{"key":"2020110410311771800_ref23","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.transproceed.2005.01.054","article-title":"Fungal infections in transplant recipients receiving alemtuzumab","volume":"37","author":"Nath","year":"2005","journal-title":"Transplant Proc"},{"key":"2020110410311771800_ref24","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1378\/chest.126.3.982","article-title":"A patient with new-onset seizure and mediastinal adenopathy","volume":"126","author":"Truong","year":"2004","journal-title":"Chest"},{"key":"2020110410311771800_ref25","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jinf.2006.05.006","article-title":"Salvage treatment of histoplasmosis with posaconazole","volume":"54","author":"Restrepo","year":"2007","journal-title":"J Infect"},{"key":"2020110410311771800_ref26","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1016\/j.jinf.2005.01.001","article-title":"A case of disseminated histoplasmosis successfully treated with the investigational drug posaconazole","volume":"51","author":"Clark","year":"2005","journal-title":"J Infect"},{"key":"2020110410311771800_ref27","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/jac\/dki288","article-title":"Activity of posaconazole in the treatment of central nervous system fungal infections","volume":"56","author":"Pitisuttithum","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"2020110410311771800_ref28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00003088-199835060-00004","article-title":"Optimisation of itraconazole therapy using target drug concentrations","volume":"35","author":"Poirier","year":"1998","journal-title":"Clin Pharmacokinet"},{"key":"2020110410311771800_ref29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00042560-199710010-00005","article-title":"Itraconazole maintenance treatment for histoplasmosis in AIDS: a prospective, multicenter trial","volume":"16","author":"Hecht","year":"1997","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"2020110410311771800_ref30","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1439-0507.1999.00518.x","article-title":"Itraconazole through concentrations in antifungal prophylaxis with six different dosing regimens using hydroxypropyl-beta-cyclodextrin oral solution or coated-pellet capsules","volume":"42","author":"Glasmacher","year":"1999","journal-title":"Mycoses"},{"key":"2020110410311771800_ref31","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1128\/AAC.50.4.1570-1572.2006","article-title":"Voriconazole therapeutic drug monitoring","volume":"50","author":"Smith","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 1","key":"2020110410311771800_ref32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1365-2125.2003.01993.x","article-title":"Voriconazole, a novel wide-spectrum triazole: oral pharmacokinetics and safety","volume":"56","author":"Purkins","year":"2003","journal-title":"Br J Clin Pharmacol"},{"key":"2020110410311771800_ref33","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1128\/AAC.50.2.658-666.2006","article-title":"Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection","volume":"50","author":"Ullmann","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2020110410311771800_ref34","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1128\/AAC.00157-06","article-title":"Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients","volume":"50","author":"Gubbins","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"2020110410311771800_ref35","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ijantimicag.2006.01.003","article-title":"Clinical pharmacokinetics of voriconazole","volume":"27","author":"Leveque","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"2020110410311771800_ref36","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1517\/14712598.6.11.1207","article-title":"Improvements in diagnosis of histoplasmosis","volume":"6","author":"Wheat","year":"2006","journal-title":"Exp Opin Biol Ther"},{"key":"2020110410311771800_ref37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1399-3062.2006.00151.x","article-title":"Elimination of false-positive Histoplasma antigenemia caused by human anti-rabbit antibodies in the second-generation Histoplasma antigen assay","volume":"8","author":"Wheat","year":"2006","journal-title":"Transpl Infect Dis"},{"key":"2020110410311771800_ref38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/13693780601185947","article-title":"Reduction in false antigenemia in the second generation Histoplasma antigen assay","volume":"45","author":"Wheat","year":"2007","journal-title":"Med Mycol"},{"key":"2020110410311771800_ref39","doi-asserted-by":"crossref","first-page":"e50","DOI":"10.1086\/511684","article-title":"Diagnosis of coccidioidomycosis by antigen detection using cross-reaction with a Histoplasma antigen","volume":"44","author":"Kuberski","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2020110410311771800_ref40","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1128\/AAC.46.1.248-250.2002","article-title":"Antigen clearance during treatment of disseminated histoplasmosis with itraconazole versus fluconazole in patients with AIDS","volume":"46","author":"Wheat","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2020110410311771800_ref41","doi-asserted-by":"crossref","first-page":"936","DOI":"10.7326\/0003-4819-115-12-936","article-title":"Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels","volume":"115","author":"Wheat","year":"1991","journal-title":"Ann Intern Med"},{"key":"2020110410311771800_ref42","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1086\/420749","article-title":"Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapy","volume":"38","author":"Goldman","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2020110410311771800_ref43","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1086\/340825","article-title":"Antifungal therapy for central nervous system histoplasmosis, using a newly developed intracranial model of infection","volume":"185","author":"Haynes","year":"2002","journal-title":"J Infect Dis"},{"key":"2020110410311771800_ref44","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1086\/315717","article-title":"Amphotericin B combined with itraconazole or fluconazole for treatment of histoplasmosis","volume":"182","author":"LeMonte","year":"2000","journal-title":"J Infect Dis"},{"key":"2020110410311771800_ref45","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1128\/AAC.44.12.3328-3336.2000","article-title":"Recombinant murine granulocyte-macrophage colony-stimulating factor modulates the course of pulmonary histoplasmosis in immunocompetent and immunodeficient mice","volume":"44","author":"Deepe","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"2020110410311771800_ref46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1286-4579(00)01347-2","article-title":"Efficacy of interferon-gamma and amphotericin B for the treatment of systemic murine histoplasmosis","volume":"3","author":"Clemons","year":"2001","journal-title":"Microbes Infect"},{"key":"2020110410311771800_ref47","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1172\/JCI19361","article-title":"Antibodies to a cell surface histone-like protein protect against Histoplasma capsulatum","volume":"112","author":"Nosanchuk","year":"2003","journal-title":"J Clin Invest"},{"key":"2020110410311771800_ref48","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1086\/432120","article-title":"Disseminated histoplasmosis in persons with interferon-gamma receptor 1 deficiency","volume":"41","author":"Zerbe","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2020110410311771800_ref49","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/00007611-198105000-00007","article-title":"Acute pulmonary histoplasmosis presenting as adult respiratory distress syndrome: effect of therapy on clinical and laboratory features","volume":"74","author":"Kataria","year":"1981","journal-title":"South Med J"},{"key":"2020110410311771800_ref50","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0002-9343(73)90028-4","article-title":"Outbreak of histoplasmosis associated with the 1970 Earth Day activities","volume":"54","author":"Brodsky","year":"1973","journal-title":"Am J Med"},{"key":"2020110410311771800_ref51","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/01.inf.0000141738.60845.da","article-title":"A large histoplasmosis outbreak among high school students in Indiana, 2001","volume":"23","author":"Chamany","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"2020110410311771800_ref52","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00005792-198107000-00001","article-title":"Histoplasmosis in normal hosts","volume":"60","author":"Goodwin","year":"1981","journal-title":"Medicine (Baltimore)"},{"key":"2020110410311771800_ref53","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJM197007302830503","article-title":"Treatment of chronic pulmonary histoplasmosis","volume":"283","author":"Parker","year":"1970","journal-title":"N Engl J Med"},{"key":"2020110410311771800_ref54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jama.1963.03700100049008","article-title":"Comparison of treated and untreated severe histoplasmosis","volume":"183","author":"Furcolow","year":"1963","journal-title":"JAMA"},{"key":"2020110410311771800_ref55","first-page":"96","article-title":"Histoplasmosis cooperative study: chronic pulmonary histoplasmosis treated with amphotericin B alone and with amphotericin B and triple sulfonamide","volume":"97","author":"Putnam","year":"1968","journal-title":"Am Rev Respir Dis"},{"key":"2020110410311771800_ref56","first-page":"641","article-title":"Histoplasmosis cooperative study: Veterans Administration-Armed Forces Cooperative Study on histoplasmosis","volume":"89","author":"Sutliff","year":"1964","journal-title":"Am Rev Respir Dis"},{"key":"2020110410311771800_ref57","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1378\/chest.58.6.562","article-title":"Follow-up of patients with chronic pulmonary histoplasmosis treated with amphotericin B","volume":"58","author":"Baum","year":"1970","journal-title":"Chest"},{"key":"2020110410311771800_ref58","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0002-9149(76)90504-X","article-title":"Pericarditis caused by Histoplasma capsulatum","volume":"37","author":"Picardi","year":"1976","journal-title":"Am J Cardiol"},{"key":"2020110410311771800_ref59","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/00005792-198303000-00004","article-title":"Pericarditis as a manifestation of histoplasmosis during two large urban outbreaks","volume":"62","author":"Wheat","year":"1983","journal-title":"Medicine (Baltimore)"},{"key":"2020110410311771800_ref60","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJM196602242740801","article-title":"Erythema nodosum and erythema multiforme as clinical manifestations of histoplasmosis in a community outbreak","volume":"274","author":"Medeiros","year":"1966","journal-title":"N Engl J Med"},{"key":"2020110410311771800_ref61","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.1780260902","article-title":"Rheumatologic manifestations of histoplasmosis in the recent Indianapolis epidemic","volume":"26","author":"Rosenthal","year":"1983","journal-title":"Arthritis Rheum"},{"key":"2020110410311771800_ref62","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1378\/chest.62.5.642","article-title":"Tracheal obstruction secondary to Histoplasma mediastinal granuloma","volume":"62","author":"Greenwood","year":"1972","journal-title":"Chest"},{"key":"2020110410311771800_ref63","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-2002-25302","article-title":"Mediastinal granuloma and mediastinal fibrosis","volume":"23","author":"Parish","year":"2002","journal-title":"Semin Respir Crit Care Med"},{"key":"2020110410311771800_ref64","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1056\/NEJM199104113241508","article-title":"Weekly clinicopathological exercises. Case 15-1991. A 48-year-old man with dysphagia, chest pain, fever, and a subcarinal mass: case records of the Massachusetts General Hospital","volume":"324","author":"Scully","year":"1991","journal-title":"N Engl J Med"},{"key":"2020110410311771800_ref65","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00005792-197205000-00008","article-title":"Mediastinal fibrosis complicating healed primary histoplasmosis and tuberculosis","volume":"51","author":"Goodwin","year":"1972","journal-title":"Medicine (Baltimore)"},{"key":"2020110410311771800_ref66","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00005792-198809000-00002","article-title":"Mediastinal fibrosis complicating histoplasmosis","volume":"67","author":"Loyd","year":"1988","journal-title":"Medicine (Baltimore)"},{"key":"2020110410311771800_ref67","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1378\/chest.117.2.482","article-title":"Mediastinal fibrosis is associated with human leukocyte antigen-A2","volume":"117","author":"Peebles","year":"2000","journal-title":"Chest"},{"key":"2020110410311771800_ref68","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/srin.2001.24242","article-title":"Mediastinal fibrosis","volume":"16","author":"Davis","year":"2001","journal-title":"Semin Respir Infect"},{"key":"2020110410311771800_ref69","first-page":"204","article-title":"Features associated with mortality in fibrosing mediastinitis [abstract A57]","volume-title":"Proceedings of the American Thoracic Society (San Diego)","author":"Martin","year":"2005"},{"key":"2020110410311771800_ref70","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0003-4975(90)90737-Q","article-title":"Sclerosing mediastinitis: improved management with histoplasmosis titer and ketoconazole","volume":"50","author":"Urschel","year":"1990","journal-title":"Ann Thorac Surg"},{"key":"2020110410311771800_ref71","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1378\/chest.75.3.320","article-title":"Mediastinal granuloma and fibrosing mediastinitis","volume":"75","author":"Dines","year":"1979","journal-title":"Chest"},{"key":"2020110410311771800_ref72","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/0003-4975(92)90069-G","article-title":"Clinical manifestation of mediastinal fibrosis and histoplasmosis","volume":"54","author":"Mathisen","year":"1992","journal-title":"Ann Thorac Surg"},{"key":"2020110410311771800_ref73","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/ajrccm.164.4.2012132","article-title":"Percutaneous pulmonary artery and vein stenting: a novel treatment for mediastinal fibrosis","volume":"164","author":"Doyle","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2020110410311771800_ref74","first-page":"1","article-title":"The enlarging histoplasmoma: concept of a tumor-like phenomenon encompassing the tuberculoma and coccidioidoma","volume":"100","author":"Goodwin","year":"1969","journal-title":"Am Rev Respir Dis"},{"key":"2020110410311771800_ref75","doi-asserted-by":"crossref","first-page":"576","DOI":"10.4269\/ajtmh.2005.73.576","article-title":"Disseminated histoplasmosis: a comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals","volume":"73","author":"Tobon","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"2020110410311771800_ref76","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1097\/01.qai.0000209927.49656.8d","article-title":"Increased incidence of disseminated histoplasmosis following highly active antiretroviral therapy initiation","volume":"41","author":"Nacher","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2020110410311771800_ref77","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.amjmed.2005.02.006","article-title":"Unusual manifestations of disseminated histoplasmosis in patients responding to antiretroviral therapy","volume":"118","author":"Shelburne","year":"2005","journal-title":"Am J Med"},{"key":"2020110410311771800_ref78","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/514744","article-title":"Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group","volume":"28","author":"McKinsey","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2020110410311771800_ref79","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1034\/j.1399-3062.2002.01016.x","article-title":"Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area","volume":"4","author":"Vail","year":"2002","journal-title":"Transpl Infect Dis"},{"issue":"Suppl 3","key":"2020110410311771800_ref80","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1086\/429996","article-title":"Reactivation of latent granulomatous infections by infliximab","volume":"41","author":"Wallis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2020110410311771800_ref81","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00005792-199007000-00006","article-title":"Histoplasma capsulatum infections of the central nervous system: a clinical review","volume":"69","author":"Wheat","year":"1990","journal-title":"Medicine (Baltimore)"},{"key":"2020110410311771800_ref82","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1086\/427880","article-title":"Diagnosis and management of central nervous system histoplasmosis","volume":"40","author":"Wheat","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2020110410311771800_ref83","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/00365540500372895","article-title":"Isolated central nervous system histoplasmosis in immunocompetent hosts: a series of 11 cases","volume":"38","author":"Schestatsky","year":"2006","journal-title":"Scand J Infect Dis"},{"key":"2020110410311771800_ref84","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1086\/315643","article-title":"Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system","volume":"182","author":"Groll","year":"2000","journal-title":"J Infect Dis"},{"key":"2020110410311771800_ref85","first-page":"44","article-title":"Spinal cord histoplasmoma: a case report","volume":"48","author":"Rivierez","year":"2002","journal-title":"Neurochirurgie"},{"key":"2020110410311771800_ref86","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/01.SMJ.0000051734.53654.D0","article-title":"Cerebral histoplasmosis in the azole era: report of four cases and review","volume":"96","author":"Saccente","year":"2003","journal-title":"South Med J"},{"key":"2020110410311771800_ref87","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1080\/00365540110077308","article-title":"Solitary parietal lobe histoplasmoma mimicking a brain tumor","volume":"34","author":"Paphitou","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"2020110410311771800_ref88","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1056\/NEJM199401273300408","article-title":"Case 4-1994\u2014a 38-year-old man with AIDS and the recent onset of diarrhea, hematochezia, fever, and pulmonary infiltrates","volume":"330","author":"Basgoz","year":"1994","journal-title":"N Engl J Med"},{"key":"2020110410311771800_ref89","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0887-8994(92)90040-6","article-title":"Chronic progressive CNS histoplasmosis presenting in childhood: response to fluconazole therapy","volume":"8","author":"Rivera","year":"1992","journal-title":"Pediatr Neurol"},{"key":"2020110410311771800_ref90","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archinte.1985.00360050135023","article-title":"Treatment of central nervous system fungal infection with ketoconazole","volume":"145","author":"Goodpasture","year":"1985","journal-title":"Arch Intern Med"},{"key":"2020110410311771800_ref91","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1086\/517242","article-title":"Successful treatment of multiple cerebral histoplasmomas with itraconazole","volume":"28","author":"Bamberger","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2020110410311771800_ref92","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s100960050368","article-title":"A case of HIV-associated cerebral histoplasmosis successfully treated with fluconazole","volume":"18","author":"Knapp","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2020110410311771800_ref93","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1517\/14740338.2.5.475","article-title":"Antifungal drugs in pregnancy: a review","volume":"2","author":"Moudgal","year":"2003","journal-title":"Exp Opin Drug Saf"},{"key":"2020110410311771800_ref94","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1001\/archinte.164.4.454","article-title":"Histoplasmosis in pregnancy: case series and report of transplacental transmission","volume":"164","author":"Whitt","year":"2004","journal-title":"Arch Intern Med"},{"key":"2020110410311771800_ref95","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/clinids\/22.2.336","article-title":"Fluconazole-induced congenital anomalies in three infants","volume":"22","author":"Pursley","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2020110410311771800_ref96","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1046\/j.1365-2125.1999.00989.x","article-title":"Risk of malformations and other outcomes in children exposed to fluconazole in utero","volume":"48","author":"Sorensen","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"2020110410311771800_ref97","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1067\/mob.2000.105962","article-title":"Pregnancy outcome after in utero exposure to itraconazole: a prospective cohort study","volume":"183","author":"Bar-Oz","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"2020110410311771800_ref98","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0002-9378(96)70119-9","article-title":"Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole","volume":"175","author":"Mastroiacovo","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"2020110410311771800_ref99","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1097\/00006454-199912000-00007","article-title":"Disseminated histoplasmosis in infants","volume":"18","author":"Odio","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"2020110410311771800_ref100","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/00006454-198811000-00012","article-title":"Disseminated histoplasmosis of infancy","volume":"7","author":"Leggiadro","year":"1988","journal-title":"Pediatr Infect Dis J"},{"key":"2020110410311771800_ref101","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jpeds.2003.10.035","article-title":"Histoplasmosis in a pediatric oncology center","volume":"144","author":"Adderson","year":"2004","journal-title":"J Pediatr"},{"key":"2020110410311771800_ref102","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/00006454-199409000-00010","article-title":"The Histoplasma capsulatum antigen assay in disseminated histoplasmosis in children","volume":"13","author":"Fojtasek","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"2020110410311771800_ref103","first-page":"32","article-title":"Histoplasmosis in childhood","volume":"17","author":"Little","year":"1962","journal-title":"Q Rev Pediatr"},{"key":"2020110410311771800_ref104","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1097\/00006454-199611000-00014","article-title":"Disseminated histoplasmosis in children: the role of itraconazole therapy","volume":"15","author":"Tobon","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"2020110410311771800_ref105","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/infdis\/156.4.687","article-title":"Immunoregulatory lymphocyte populations in disseminated histoplasmosis of infancy","volume":"156","author":"Clapp","year":"1987","journal-title":"J Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/45\/7\/807\/34127229\/45-7-807.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/45\/7\/807\/34127229\/45-7-807.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,22]],"date-time":"2021-08-22T19:25:22Z","timestamp":1629660322000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/45\/7\/807\/541502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10,1]]},"references-count":105,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2007,10,1]]},"published-print":{"date-parts":[[2007,10,1]]}},"URL":"https:\/\/doi.org\/10.1086\/521259","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published-other":{"date-parts":[[2007,10,1]]},"published":{"date-parts":[[2007,10,1]]}}}